[go: up one dir, main page]

SG11202106222YA - Compositions and methods for the treatment of "plaques and tangles" in humans and animals - Google Patents

Compositions and methods for the treatment of "plaques and tangles" in humans and animals

Info

Publication number
SG11202106222YA
SG11202106222YA SG11202106222YA SG11202106222YA SG11202106222YA SG 11202106222Y A SG11202106222Y A SG 11202106222YA SG 11202106222Y A SG11202106222Y A SG 11202106222YA SG 11202106222Y A SG11202106222Y A SG 11202106222YA SG 11202106222Y A SG11202106222Y A SG 11202106222YA
Authority
SG
Singapore
Prior art keywords
tangles
plaques
humans
animals
compositions
Prior art date
Application number
SG11202106222YA
Inventor
Alan Snow
Original Assignee
Cognitive Clarity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognitive Clarity Inc filed Critical Cognitive Clarity Inc
Publication of SG11202106222YA publication Critical patent/SG11202106222YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/06—Treating tea before extraction; Preparations produced thereby
    • A23F3/14—Tea preparations, e.g. using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SG11202106222YA 2018-12-12 2019-11-26 Compositions and methods for the treatment of "plaques and tangles" in humans and animals SG11202106222YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862778875P 2018-12-12 2018-12-12
PCT/US2019/063455 WO2020123152A1 (en) 2018-12-12 2019-11-26 Compositions and methods for the treatment of "plaques and tangles" in humans and animals

Publications (1)

Publication Number Publication Date
SG11202106222YA true SG11202106222YA (en) 2021-07-29

Family

ID=71071419

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202106222YA SG11202106222YA (en) 2018-12-12 2019-11-26 Compositions and methods for the treatment of "plaques and tangles" in humans and animals

Country Status (12)

Country Link
US (1) US11491201B2 (en)
EP (1) EP3893907A4 (en)
JP (1) JP2022512372A (en)
CN (2) CN118845912A (en)
AU (1) AU2019397260A1 (en)
CA (1) CA3122687A1 (en)
CO (1) CO2021008890A2 (en)
DO (1) DOP2021000110A (en)
MX (1) MX2021006987A (en)
PH (1) PH12021551342A1 (en)
SG (1) SG11202106222YA (en)
WO (1) WO2020123152A1 (en)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683698A (en) * 1996-08-02 1997-11-04 New England Deaconess Hospital Formulation for alleviating symptoms associated with arthritis
US6264994B1 (en) 1997-05-15 2001-07-24 University Of Washington Compositions for treating alzheimer's disease and other amyloidoses
US6346280B1 (en) * 1997-05-15 2002-02-12 University Of Washington Composition and methods for inhibiting the formation of brain amyloid deposits
EP1019044B1 (en) 1997-05-15 2007-04-11 University of Washington Composition and methods for treating alzheimer's disease and other amyloidoses
EP1064013A4 (en) 1998-03-13 2005-05-11 Univ Washington IN VITRO-EDUCATION KONGOPHILER AMYLOIDER PLAQUES IN THE FORM OF MALTESE CROSSES FOR THE IDENTIFICATION OF ANTIPLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER AND PRION DISEASES
JP2003171298A (en) 2001-12-11 2003-06-17 Nonogawa Shoji Kk Antiallergic agent
US8034387B2 (en) 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070190075A1 (en) 2003-10-09 2007-08-16 Advangen, Inc. C/O National Institute Of Advance Science And Tech Hair growth stimulant composition
BRPI0509372A (en) * 2004-03-30 2007-09-11 Unilever Nv composition, skin lightening product, methods of inhibiting melanin production, increasing the ratio of light melanin to dark melanin in the skin of a mammal, and inhibiting the transport of melanin from melanocytes to an individual's skin. keratinocytes, and use of a composition
JP4321769B2 (en) 2004-04-13 2009-08-26 Ｔｏｗａ Ｃｏｒｐｏｒａｔｉｏｎ 株式会社 Composition for antihistamine, composition for prevention and treatment of allergic rhinitis, composition for prevention and treatment of hay fever and composition for treatment of urticaria
JP4954552B2 (en) 2006-01-07 2012-06-20 日本メナード化粧品株式会社 Antiallergic agent
JP2007230977A (en) 2006-03-03 2007-09-13 Naris Cosmetics Co Ltd Production inhibitor ii for granulocyte/macrophage colony stimulating factor (gm-csf)
JP2007277163A (en) 2006-04-06 2007-10-25 Uha Mikakuto Co Ltd Dipeptidyl peptidase iv inhibitor
TW200812637A (en) 2006-09-15 2008-03-16 jun-er Wang Vegetable composition for cleaning oral cavity
JP2010013423A (en) 2008-07-07 2010-01-21 Lion Corp Dipeptidyl peptidase-iv inhibitor
JP5688606B2 (en) * 2012-02-17 2015-03-25 株式会社シェフコ Method for producing hydrogen-containing beverage containing functional ingredients
SG11201706861QA (en) 2015-02-27 2017-09-28 Cognitive Clarity Inc Compositions and methods for the treatment of "plaques and tangles" in humans and animals
WO2017200391A1 (en) * 2016-05-17 2017-11-23 Alphagen Nz Limited Compositions comprising l-theanine, proanthocyanidin/s and a catechin and uses thereof
CN109475848B (en) 2016-07-29 2021-11-19 宝洁公司 Catalyst for preparing acrylic acid from lactic acid or its derivative in liquid phase

Also Published As

Publication number Publication date
CO2021008890A2 (en) 2021-07-30
DOP2021000110A (en) 2021-12-15
EP3893907A1 (en) 2021-10-20
EP3893907A4 (en) 2022-11-30
US11491201B2 (en) 2022-11-08
MX2021006987A (en) 2021-08-11
CN118845912A (en) 2024-10-29
PH12021551342A1 (en) 2021-12-13
US20200188467A1 (en) 2020-06-18
JP2022512372A (en) 2022-02-03
AU2019397260A1 (en) 2021-06-24
CN113301906A (en) 2021-08-24
WO2020123152A1 (en) 2020-06-18
CA3122687A1 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
IL268406A (en) Compositions and methods for the treatment of hemoglobinopathies
IL273959A (en) Methods and compositions for the treatment of rare diseases
SG11202011296VA (en) Compositions and methods for the treatment of parkinson's disease
IL275626A (en) Surface treatment compositions and methods
IL286636A (en) Compositions and methods for the treatment of kras associated diseases or disorders
IL277182A (en) Compositions and methods for treating parkinson's disease
IL287796A (en) Compositions and methods for the treatment of atpase-mediated diseases
GB201820450D0 (en) Compound and its use for the treatment of alpha1-antitryspin deficiency
IL268502A (en) Triplet combination formulations and methods of treating or reducing the risk of cardiovascular disease
ZA202006234B (en) Compositions and methods for the treatment of neurological diseases
ZA202007834B (en) Compositions comprising amino acids for use in the prevention and treatment of liver diseases
IL275767A (en) Compositions and methods for treating metabolic diseases
SG11202100675YA (en) Surface treatment compositions and methods
IL286767A (en) Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease
ZA202101489B (en) Compositions and methods for the treatment of parkinson's disease
PT3810128T (en) Compositions for treating and/or preventing protein-aggregation diseases
SG11201706861QA (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
GB201918404D0 (en) Compounds and their use for the treatment of aplha1-antitrypsin deficiency
SG11202106222YA (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
IL261779A (en) Compositions for the treatment and prevention of hoof and claw diseases
HK40052550A (en) Compositions and methods for the treatment of "plaques and tangles" in humans and animals
IL276228A (en) Compounds and compositions for the treatment of pain
IL282739A (en) Compositions and methods for the treatment of smooth muscle dysfunction
IL265911A (en) Apilimod compositions and methods for using same in the treatment of alzheimer's disease
ZA201801945B (en) Compositions and methods for the treatment of parkinson's disease